Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04762043
Other study ID # EMG Voice Restoration
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 12, 2021
Est. completion date March 2023

Study information

Verified date March 2022
Source Altec Inc.
Contact Jennifer M Vojtech, PhD
Phone 5085458208
Email jvojtech@altecresearch.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will evaluate the ability of MyoVoice to replace natural speech. Referred to generally as an Augmentative and Alternative Communication (AAC) device, MyoVoice uses electrical signals recorded non-invasively from speech muscles (electromyographic, or EMG, signals) to restore communication for those with vocal impairments that resulted from surgical treatment of laryngeal and oropharyngeal cancers.


Description:

Over 7.5 million people worldwide are unable to vocalize effectively. Among these individuals are cancer survivors who underwent oropharyngeal/laryngeal surgery and must rely on AAC systems such as text-to-speech applications or artificial voice prostheses as substitutes for their natural voice. Yet most of these devices struggle to convey the expressive attributes of speech (prosody), leading to poor comprehension and a lack of emotional content. The clinical trial will investigate the feasibility of MyoVoice-a novel AAC device that uses surface EMG signals to extract patterns for understanding vocabulary and expressive attributes from articulatory musculature during silently mouthed speech-to effectively restore conversational capabilities for individuals living with vocal impairments due to surgical treatment of laryngeal and oropharyngeal cancers. Patients who underwent a total laryngectomy will be asked to communicate with a conversational partner by silently mouthing words using MyoVoice. The device performance will be evaluated in terms of its ability to accurately and quickly translate articulatory muscle activity into audible speech. MyoVoice will also be compared to that of conventional electrolaryngeal speech aids (i.e., artificial larynx) to evaluate device ease-of-use, functional efficacy, and social reception.


Recruitment information / eligibility

Status Recruiting
Enrollment 28
Est. completion date March 2023
Est. primary completion date March 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 25 Years and older
Eligibility Inclusion Criteria: Control Subjects: - Primary English speaker - No history of speech, language, cognitive, or hearing disorders - Normal hearing (able to pass a bilateral hearing screening using a threshold of 25 dB HL at 125, 250, 500, 1000, 2000, 4000, and 8000 Hz based on the American Speech-Language-Hearing Association) - Capable of signed informed consent Laryngectomy Subjects: - At least 6 months S/P total laryngectomy - Proficient electrolarynx (EL) speaker - Primary English speaker - Sufficiently available and sufficiently healthy to comply with multiple test sessions lasting 4-6 hours - Capable of signed informed consent Exclusion Criteria: Control Subjects: - Inability to understand spoken English or follow simple instructions - History of speech, language, cognitive, or hearing disorders - Inability to provide written informed consent Laryngectomy Subjects: - Inability to understand spoken English or follow simple instructions - Loss of adequate sEMG sensor sites for recording from muscles of articulation due to Cancer treatment - Skin disorders or radiation/surgical scarring that prevent the use of medical-grade adhesive tapes for securing sensors - Inability to provide written informed consent - Any other medical or psychological condition that is based on the opinion of the investigators will prevent participation in the experiment (e.g., the candidate may have an illness that makes them fatigue easily or have difficulty to attend to visual cues)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
MyoVoice
Person-centric AAC system comprising a user-specific set of wearable sensors for capturing articulatory muscle activity and mobile software that provides real-time audible speech outputs.
Electrolarynx
Hand-operated electromechanical device that operates as an artificial larynx to enable a person after laryngectomy to produce speech.

Locations

Country Name City State
United States Altec Inc. Natick Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
Altec Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Word Recognition Rate Accuracy of identifying individual words from a designated speech corpus that are automatically transcribed using the AAC device. 1 hour
Primary Prosody Recognition Rate Accuracy of identifying prosodic tone and break index (ToBI) categories from a designated speech corpus that are automatically classified using the AAC device. 1 hour
Primary System Usability Scale Ten-question Likert scale assessment giving a global view of subjective, qualitative assessments of device usability. Participants will rank each question from 1 ("strongly disagree") to 5 ("strongly agree") based on how much they agree with the statement they are reading. 1 hour
Primary Test-Retest Reliability Repeatability of word and prosody recognition rates obtained when placing and replacing the reusable, wearable sEMG sensor veneer. 1 hour
Primary Intelligibility The degree to which a speaker's message can be recovered by a listener, as measured via listeners orthographically transcribing words from audio samples. 1 hour
Primary Comprehensibility The degree to which a listener understands the meaning of a speaker's message (e.g., if the phrase is "Jane loves Bob," the listener may be asked to respond to "Who loves Bob?"). 1 hour
Primary Device Comfort Perceived assessment of user comfort when wearing the MyoVoice device as captured via a Likert scale ranked from 1 ("not at all comfortable") to 5 ("very comfortable"). 1 hour
Secondary MyoVoice Translation Speed Duration in which the MyoVoice system carries out sEMG-to-speech synthesis relative to the length and content of the message being synthesized. 1 hour
Secondary Acceptability The degree to which naïve listeners find a speech sample to be "acceptable" relative to attributes of pitch, rate, understandability and voice quality. 1 hour
Secondary Acoustic Identity The accuracy in which naïve listeners select which voice sample best matches that of a presented speech sample. 1 hour
Secondary Emotional Content Naïve listeners will complete a single multiple-choice question to qualitatively assess the perceived emotional content conveyed by each speech sample. Listeners will select a single emotion they feel BEST represents that which was conveyed by the speech sample from a list of the seven fundamental emotions of "sadness," "anger," "happiness," "disgust," "surprise," "fear," and "neutral." 1 hour
Secondary Prosodic sEMG-Acoustic Correlation Correlation between recognized (sEMG) and ground-truth (acoustic) prosodic tone and break indices (ToBI) measured during speaking tasks. 1 hour
See also
  Status Clinical Trial Phase
Recruiting NCT02909088 - Efficacy and Tolerability of Ecopipam in Adults With Childhood Onset Fluency Disorder (Stuttering). Phase 2/Phase 3
Recruiting NCT05695131 - Clinical Feasibility & Validation of the Virtual Reality GlenxRose Speech-Language Therapies N/A
Recruiting NCT04117360 - Orthognathic Speech Pathology: Phonetic Contrasts of Patients With Dental Discrepancies Pre- and Post-Treatment Analyses
Completed NCT02288598 - Enhancing Speech Fluency With Non-invasive Brain Stimulation in Developmental Stuttering N/A
Completed NCT02490826 - Table to Tablet (T2T): A Novel Intervention Framework for Children With Speech Sound Disorders N/A
Not yet recruiting NCT04528147 - Yi Jin Jing Tiger Roaring Speech Rehabilitation With Real-Time Feedback Technique for PD N/A
Completed NCT02554513 - Apraxia of Speech: Comparison of EPG Treatment (Tx) and Sound Production Treatment (SPT) N/A
Recruiting NCT05876247 - Articulatory Adaptation Following Oral Cancer Treatment
Recruiting NCT05489965 - Gender Disparities in Voice Outcomes After Tracheoesophageal Puncture in Total Laryngectomy Patients (UC Davis)
Completed NCT02752425 - Visual Feedback of Tongue by Ultrasound Echography for Speech Trouble Rehabilitation N/A
Recruiting NCT06443073 - The Mere-measurement Effect of Patient-reported Outcomes N/A
Recruiting NCT05741853 - Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia N/A
Completed NCT04026581 - Real World Testing of a Brain-Computer Interface
Active, not recruiting NCT04937452 - Dopaminergic Therapy for Frontotemporal Dementia Patients Phase 2
Completed NCT02416856 - Brain Connectivity Supporting Language Recovery in Aphasia
Completed NCT01180309 - Lingual Frenum and Articulation of Phonemes N/A
Completed NCT03663972 - Age-related Correlates of Treatment for Late-acquired Sounds N/A
Not yet recruiting NCT04323085 - Speech-in-Noise Treatments for Hypophonia in Parkinson's Disease Phase 2
Completed NCT00125242 - Word-Retrieval Treatment for Aphasia: Semantic Feature Analysis N/A
Completed NCT04966689 - The Effect of Combined Speech and Music-therapy on the Speech Characteristics of People With Parkinson's Disease (PD) N/A